Keyphrases
Cesarean Delivery
100%
Antibiotic Use
85%
Hazard Ratio
78%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
71%
Survival Prognosis
71%
Motivational Enhancement Therapy
71%
Randomized Controlled Trial
71%
National Cohort
71%
Infant Gut Microbiota
71%
Prostate Cancer
71%
Prognostic Model
71%
Heparin Lock
71%
Attention Deficit Hyperactivity Disorder
71%
Prognostic Factors
71%
Alcohol Use Disorder
71%
Early childhood
71%
Data Quality
71%
Home Parenteral Support
71%
Design Study
71%
Autism
71%
Taurolidine-citrate
71%
Catheter-related Bloodstream Infection (CRBSI)
71%
Prostate Cancer Patients
71%
Quality Screening
71%
DSM-5
71%
Microbiota
50%
Confidence Interval
42%
Between-within
42%
Imputation Techniques
35%
Prostate-specific Antigen
35%
Generalized Additive Model
35%
Data Usage
35%
Broad-spectrum Antibiotics
35%
Statistical Techniques
35%
Least Absolute Shrinkage and Selection Operator (LASSO)
35%
Prediction Accuracy
35%
Individual Survival
35%
Model Fitting
35%
Tree-based
35%
Prognostic Value
35%
Cox Model
35%
Survival Time
35%
Training Data
35%
Antibiotics
35%
Denmark
28%
Antibiotic Treatment
28%
Unmeasured Confounding
28%
Cesarean
28%
Interactive Data
23%
R Tool
23%
Medicine and Dentistry
Cesarean Section
91%
Prostate Cancer
71%
Taurolidine
71%
Autism
71%
Alcoholic Polyneuropathy
71%
Group Therapy
71%
Attention Deficit Disorder
71%
Randomized Controlled Trial
71%
Proportional Hazards Model
64%
Hazard Ratio
57%
Antibiotics
33%
Alcohol
28%
Broad-Spectrum Antibiotic
26%
Intrapartum
23%
Antibiotic Therapy
23%
Infancy
20%
Survival Time
17%
Prostate Specific Antigen
17%
Cross-Validation
17%
Disease Marker
16%
Prospective Cohort Study
16%
Penicillin
16%
Vaginal Delivery
16%